EVOGENE (Israel) Quote Today

EVOGENE is trading at 937.10 as of the 26th of September 2021, a 0.76 percent increase since the beginning of the trading day. The stock's open price was 930.0. Equity ratings for EVOGENE LTD are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of February 2020 and ending today, the 26th of September 2021. Click here to learn more.
Valuation Profit Patterns
Check how we calculate scores

EVOGENE Stock Profile

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel. EVOGENE operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 131 people. more on EVOGENE
EVOGENE LTD is not yet fully synchronised with the market data
EVOGENE LTD generates negative expected return over the last 90 days
EVOGENE LTD has high historical volatility and very poor performance
The company reported the revenue of 1.14 M. Net Loss for the year was (25.72 M) with profit before overhead, payroll, taxes, and interest of 466 K.
EVOGENE LTD has accumulated about 65.36 M in cash with (22.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.61.
Legal NameEVOGENE LTD
CEOOfer Haviv  (View All)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of EVOGENE's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedOvervalued
EVOGENE LTD (EVGN) is traded on Tel Aviv Stock Exchange in Israel and employs 131 people. The company currently falls under 'Large-Cap' category with current market capitalization of 37.87 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate EVOGENE's market, we take the total number of its shares issued and multiply it by EVOGENE's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. EVOGENE LTD operates under Healthcare sector and is part of Biotechnology industry. The entity has 40.41 M outstanding shares. EVOGENE LTD has accumulated about 65.36 M in cash with (22.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.61.
Check EVOGENE Probability Of Bankruptcy

EVOGENE Stock Price Odds Analysis

What are EVOGENE's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of EVOGENE jumping above the current price in 90 days from now is about 82.36%. The EVOGENE LTD probability density function shows the probability of EVOGENE stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon EVOGENE has a beta of 0.6553 suggesting as returns on the market go up, EVOGENE average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding EVOGENE LTD will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. EVOGENE LTD is significantly underperforming DOW.
 Odds Down 937.1HorizonTargetOdds Up 937.1 
17.57%90 days
 937.10 
82.36%
Based on a normal probability distribution, the odds of EVOGENE to move above the current price in 90 days from now is about 82.36 (This EVOGENE LTD probability density function shows the probability of EVOGENE Stock to fall within a particular range of prices over 90 days) .

EVOGENE Historical Income Statement

EVOGENE LTD Income Statement is one of the three primary financial statements used for reporting EVOGENE's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of EVOGENE LTD revenue and expense. EVOGENE Income Statement primarily focuses on the company's revenues and expenses during a particular period.
EVOGENE Direct Expenses is projected to decrease significantly based on the last few years of reporting. The past year's Direct Expenses was at 574,000. The current year Revenues is expected to grow to about 1.1 M, whereas Net Income is forecasted to decline to (25.2 M). View More Fundamentals

EVOGENE Stock Against Markets

Picking the right benchmark for EVOGENE stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in EVOGENE stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for EVOGENE is critical whether you are bullish or bearish towards EVOGENE LTD at a given time.

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with EVOGENE stock to make a market-neutral strategy. Peer analysis of EVOGENE could also be used in its relative valuation, which is a method of valuing EVOGENE by comparing valuation metrics with similar companies.

EVOGENE Corporate Directors

EVOGENE corporate directors refer to members of an EVOGENE board of directors. The board of directors generally takes responsibility for the EVOGENE's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of EVOGENE's board members must vote for the resolution. The EVOGENE board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Oded Shoseyov - DirectorProfile
Adina Makover - Independent DirectorProfile
Adrian Percy - DirectorProfile
Sarit Firon - Independent DirectorProfile
Continue to Investing Opportunities. Note that the EVOGENE LTD information on this page should be used as a complementary analysis to other EVOGENE's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Tools for EVOGENE Stock

When running EVOGENE LTD price analysis, check to measure EVOGENE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EVOGENE is operating at the current time. Most of EVOGENE's value examination focuses on studying past and present price action to predict the probability of EVOGENE's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move EVOGENE's price. Additionally, you may evaluate how the addition of EVOGENE to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go